BioCentury
ARTICLE | Clinical News

Altropane: Completed Phase III enrollment

February 9, 2009 8:00 AM UTC

Alseres completed enrollment of 60 patients in the open-label first stage of the Phase III POET-2 program. The first stage was designed to acquire a set of Altropane images that will be used to train ...